Next Financial Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-358
| Closed | -$15K | – | 2435 |
|
2020
Q3 | $15K | Buy |
+358
| New | +$15K | ﹤0.01% | 1515 |
|
2020
Q2 | – | Sell |
-358
| Closed | -$16K | – | 1969 |
|
2020
Q1 | $16K | Buy |
358
+46
| +15% | +$2.06K | ﹤0.01% | 1373 |
|
2019
Q4 | $19K | Sell |
312
-3
| -1% | -$183 | ﹤0.01% | 1554 |
|
2019
Q3 | $18K | Hold |
315
| – | – | ﹤0.01% | 1496 |
|
2019
Q2 | $18K | Hold |
315
| – | – | ﹤0.01% | 1507 |
|
2019
Q1 | $16K | Hold |
315
| – | – | ﹤0.01% | 1017 |
|
2018
Q4 | $13K | Buy |
315
+115
| +58% | +$4.75K | ﹤0.01% | 1272 |
|
2018
Q3 | $14K | Buy |
+200
| New | +$14K | 0.01% | 904 |
|
2017
Q4 | – | Sell |
-200
| Closed | -$10K | – | 1477 |
|
2017
Q3 | $10K | Buy |
+200
| New | +$10K | ﹤0.01% | 1230 |
|
2017
Q1 | – | Sell |
-200
| Closed | -$16K | – | 2343 |
|
2016
Q4 | $16K | Hold |
200
| – | – | ﹤0.01% | 1472 |
|
2016
Q3 | $14K | Buy |
+200
| New | +$14K | ﹤0.01% | 1524 |
|
2014
Q4 | – | Sell |
-2,500
| Closed | -$32K | – | 2405 |
|
2014
Q3 | $32K | Hold |
2,500
| – | – | 0.01% | 1183 |
|
2014
Q2 | $26K | Buy |
+2,500
| New | +$26K | 0.01% | 516 |
|